Thermage FLX +
Clear + Brilliant

Combination treatment can sound like “more is better.” In evidence-based aesthetic care, the better question is whether each technology addresses a distinct concern, whether the sequence is appropriate for the individual, and whether the expected benefit justifies the added time, cost, and risk.

Two technologies with different jobs

Thermage FLX: monopolar radiofrequency

Thermage FLX uses monopolar radiofrequency energy. The FDA 510(k) summary describes the system as delivering RF energy while conductively cooling the epidermis and monitoring skin contact. Its cleared indications include non-invasive treatment of periorbital wrinkles and wrinkles and rhytids. The manufacturer describes gradual collagen remodeling, with visible changes that may continue to develop over several months.

In practical terms, Thermage is generally discussed when skin firmness, laxity, or contour is the central concern. It does not replace surgery, restore lost facial volume, or correct every cause of an aging appearance.

Clear + Brilliant: nonablative fractional laser

Clear + Brilliant creates microscopic treatment zones with a nonablative fractional laser while leaving surrounding tissue intact. It is generally used as a series for concerns such as early photoaging, uneven tone, and texture. Because it works differently from radiofrequency, it may be considered when a patient has both laxity-related and surface-quality goals.

What did the 2025 study examine?

A prospective, single-arm study published in Dermatologic Surgery enrolled 20 women with mild to moderate facial skin laxity and photoaging. Participants received one Thermage FLX treatment followed by four Clear + Brilliant Touch treatments using 1440-nm and 1927-nm wavelengths.

Researchers used clinical grading scales, blinded photographic review, and participant satisfaction measures. At six months, the investigators reported statistically significant improvements in skin-laxity and photoaging scores. Blinded reviewers correctly identified 67% of post-treatment photographs, and 77% of participants were categorized as responders.

The study is useful because it evaluated a real-world question: whether a sequence targeting deeper firmness and more superficial texture or pigmentation could produce a broader visible change. It also followed participants long enough to capture some of the gradual remodeling expected after radiofrequency.

What the study cannot prove

The research was small, included only 20 participants, and did not have a randomized comparison group. Because everyone received both technologies, the study cannot tell us how much improvement came from Thermage, how much came from Clear + Brilliant, or whether the combined sequence was superior to either treatment alone.

Participants were women selected for mild to moderate laxity and photoaging. The findings should not be generalized automatically to all genders, skin types, degrees of laxity, medical histories, or treatment goals. Photographic review and satisfaction measures are clinically useful but still differ from large, controlled trials with objective long-term endpoints.

Finally, a statistically significant average change does not predict one person’s result. Anatomy, baseline collagen, sun exposure, smoking history, hormonal changes, previous procedures, skincare, and the treatment plan can all influence the outcome.

How a personalized sequence is planned

1. Define the primary concern

If laxity is the main issue, the consultation should clarify whether non-invasive radiofrequency is likely to produce a meaningful degree of change. If pigmentation, roughness, or early photodamage is more prominent, a fractional laser plan may be prioritized. When both are present, combining modalities may be discussed.

2. Review skin type, timing, and recent procedures

Energy-based treatments require an accurate history. The provider should review medications, active skin conditions, implanted electrical devices, prior fillers or energy treatments, pregnancy or breastfeeding status, tendency toward pigment change, and upcoming sun exposure or events. The Thermage manufacturer specifically lists an implanted pacemaker, cardioverter, defibrillator, or other electrical implant as a contraindication and provides additional important safety information.

3. Decide whether treatments should be staged

The 2025 study used one radiofrequency treatment followed by a series of four fractional laser treatments. That research protocol is not a prescription for every patient. Sequence and spacing should be selected by the treating professional based on tissue response, treatment intensity, tolerance, and the patient’s priorities.

4. Set expectations before treatment

Thermage changes are generally assessed over months as collagen remodeling develops. Clear + Brilliant is commonly planned as a series, and temporary redness, warmth, swelling, dryness, or a sandpaper-like texture may occur depending on the treatment. Individual experiences and results vary.